Loteprednol
From Wikipedia, the free encyclopedia
| Image:Loteprednol.png | |
| Loteprednol
| |
| Systematic (IUPAC) name | |
| chloromethyl 17-ethoxycarbonyloxy- 11-hydroxy- 10,13-dimethyl-3-oxo- 7,8,9,11,12,14,15, 16-octahydro- 6H-cyclopenta[a] phenanthrene-17-carboxylate | |
| Identifiers | |
| CAS number | 82034-46-6 |
| ATC code | S01BA14 |
| PubChem | 444025 |
| DrugBank | APRD01078 |
| Chemical data | |
| Formula | C24H31ClO7 |
| Mol. weight | 466.951 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Loteprednol (or loteprednol etabonate) is a corticosteroid used in ophthalmology.

